Bio safety Testing Market By Product (Reagents and Kits, Instruments, and Other Products), By Test (Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Endotoxin Tests, Adventitious Agent Detection Tests, and Other Tests), By Application (Vaccines and Therapeutics, Cellular and Gene Therapy, Blood and Blood-based Therapy, and Other Applications), and By Region - Trends, Analysis, and Forecast till 2029

Bio safety testing market was valued at US$ 3.1 billion in 2019 and is projected to grow at a compound annual growth rate of 13.1% to reach US$ 10.5 billion by 2029.

Testing procedures used to verify that vaccines and biopharmaceuticals are not contaminated as well as to ensure compliance with relevant regulations are referred to as biosafety testing. This covers, among other things, various characterization tests, sterility tests, bioburden and cell line authentication tests, endotoxin tests, adventitious agent detection tests, and tests for residual host contamination.